Advicenne S.A. (EPA:ALDVI)
1.200
-0.114 (-8.68%)
Jun 3, 2026, 5:35 PM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €19.12 million as of June 3, 2026. Its market cap has decreased by -7.50% in one year.
Market Cap
19.12M
Enterprise Value
36.77M
Revenue
6.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.20
Market Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 19.12M, a decrease of -82.94%. That is a compound annual growth rate of -18.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 19.12M | -22.01% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 33.84M |
| genOway Société anonyme | 22.04M |
| GenSight Biologics | 20.75M |
| Aelis Farma | 17.13M |
| NFL Biosciences | 13.00M |
| Aton | 12.59M |
| Poxel | 12.30M |
| TME Pharma | 8.10M |